Law firm Levi & Korsinsky has filed a class action securities lawsuit against Neumora Therapeutics (NMRA) alleging the company made false statements and concealed critical information about its Phase Two clinical trials for Navacaprant, a therapeutic candidate for Major Depressive Disorder (MDD). The lawsuit claims Neumora manipulated trial inclusion criteria and statistical analysis to show potential efficacy, despite inadequate data.